Alyeska Investment Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-118,351	Closed	-$1.73M	–	494
2019 Q2	$1.73M	Buy	+118,351	New	+$1.73M	0.02%	305